Skip to main content

Table 4 Factors associated with degree of uptake in 18F-fluorodeoxyglucose and 18F-fluoroestradiol PET/CT

From: Head-to-head comparison of 18F-FDG and 18F-FES PET/CT for initial staging of ER-positive breast cancer patients

Factor

18F-fluorodeoxyglucose

18F-fluoroestradiol

Correlation coefficient (95% C.I.)

p-value

Correlation coefficient (95% C.I.)

p-value

Age (year)

0.01 (− 0.14, 0.16)

0.937

0.12 (− 0.08, 0.31)

0.233

BMI (kg/m2)

0.16 (− 0.37, 0.69)

0.551

0.45 (− 0.21, 1.12)

0.181

Menopause status

No

Ref

 

Ref

 

Yes

− 0.33 (− 5.30, 4.65)

0.898

5.74 (− 0.54, 12.01)

0.073

Cell type

    

Invasive ductal carcinoma

Ref

 

Ref

 

Invasive lobular carcinoma

− 5.32 (− 11.48, 0.84)

0.090

1.46 (− 4.26, 7.19)

0.616

Invasive micropapillary carcinoma

− 0.95 (− 10.24, 8.33)

0.841

− 0.64 (− 8.24, 6.95)

0.868

Mucinous carcinoma

− 5.04 (− 14.18, 4.10)

0.280

26.65 (19.28, 34.02)

 < 0.001

Intensity of ER expression

Weak

Ref

 

Ref

 

Moderate

− 1.87 (− 10.22, 6.48)

0.660

0.34 (− 10.21, 10.90)

0.949

Strong

− 3.82 (− 9.04, 1.40)

0.152

5.83 (− 0.56, 12.22)

0.074

Proportion of ER expression

 < 1%

 

 

1-10%

Ref

 

Ref

 

11-33%

0.22 (− 10.34, 10.79)

0.967

− 1.33 (− 14.63, 11.96)

0.844

34-66%

− 0.64 (− 8.03, 6.75)

0.865

3.20 (− 6.00, 12.41)

0.495

 > 67%

− 2.39 (− 7.87, 3.09)

0.393

5.84 (− 0.75, 12.43)

0.082

Allred Score

 < 7

Ref

 

Ref

 

7–8

− 3.60 (− 8.38, 1.18)

0.140

5.90 (− 0.0005, 11.81)

0.050

Luminal

A

Ref

 

Ref

 

B

2.76 (1.10, 11.92)

0.018

− 1.39 (− 5.11, 2.34)

0.465

Ki-67

0.11 (0.01, 0.20)

0.025

− 0.06 (− 0.12, 0.01)

0.096

  1. BMI Body mass index, ER Estrogen receptor